Title : Crizotinib reduces the rate of dark adaptation in the rat retina independent of ALK inhibition.

Pub. Date : 2015 Jan

PMID : 25326243






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib (Xalkori) is a tyrosine kinase inhibitor of both anaplastic lymphoma kinase (ALK) and mesenchymal-epithelial transition factor (c-Met). Crizotinib MET proto-oncogene, receptor tyrosine kinase Rattus norvegicus